Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study
- 7 February 2012
- journal article
- research article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 28 (3) , 371-378
Abstract
(2012). Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study. Current Medical Research and Opinion: Vol. 28, No. 3, pp. 371-378. doi: 10.1185/03007995.2012.657302Keywords
This publication has 36 references indexed in Scilit:
- Statin-induced myopathy: a review and updateExpert Opinion on Drug Safety, 2011
- Stemming the global tsunami of cardiovascular diseaseThe Lancet, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Approach to the Patient Who Is Intolerant of Statin TherapyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Narrative Review: Statin-Related MyopathyAnnals of Internal Medicine, 2009
- The safety of statins in clinical practiceThe Lancet, 2007
- Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)European Journal of Preventive Cardiology, 2007
- JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practiceHeart, 2005
- A Comprehensive Description of Muscle Symptoms Associated with Lipid-Lowering DrugsCardiovascular Drugs and Therapy, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001